HomeANIP • NASDAQ
add
ANI Pharmaceuticals Inc Common Stock
Previous close
$62.03
Day range
$61.98 - $62.70
Year range
$48.20 - $70.81
Market cap
1.31B USD
Avg Volume
175.64K
P/E ratio
39.07
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 137.43M | 28.70% |
Operating expense | 73.22M | 28.25% |
Net income | 18.21M | 1,165.25% |
Net profit margin | 13.25 | 881.48% |
Earnings per share | 1.21 | 3.42% |
EBITDA | 29.74M | 11.45% |
Effective tax rate | 28.13% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 238.25M | 251.63% |
Total assets | 914.52M | 19.51% |
Total liabilities | 437.71M | 2.81% |
Total equity | 476.81M | — |
Shares outstanding | 19.41M | — |
Price to book | 2.67 | — |
Return on assets | 4.14% | — |
Return on capital | 4.96% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 18.21M | 1,165.25% |
Cash from operations | 18.27M | -14.73% |
Cash from investing | 8.93M | 479.64% |
Cash from financing | -19.73M | -333.73% |
Net change in cash | 7.48M | -48.52% |
Free cash flow | 11.19M | -74.93% |
About
Founded
2001
Headquarters
Website
Employees
642